Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Identification of liver cancer-specific aptamers using whole live cells.

Shangguan D, Meng L, Cao ZC, Xiao Z, Fang X, Li Y, Cardona D, Witek RP, Liu C, Tan W.

Anal Chem. 2008 Feb 1;80(3):721-8. doi: 10.1021/ac701962v.

PMID:
18177018
2.

Selection of aptamers for molecular recognition and characterization of cancer cells.

Tang Z, Shangguan D, Wang K, Shi H, Sefah K, Mallikratchy P, Chen HW, Li Y, Tan W.

Anal Chem. 2007 Jul 1;79(13):4900-7.

PMID:
17530817
3.

Use of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cells.

Graham JC, Zarbl H.

PLoS One. 2012;7(4):e36103. doi: 10.1371/journal.pone.0036103.

4.

Generating aptamers for recognition of virus-infected cells.

Tang Z, Parekh P, Turner P, Moyer RW, Tan W.

Clin Chem. 2009 Apr;55(4):813-22. doi: 10.1373/clinchem.2008.113514.

5.

CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2.

Chen F, Hu Y, Li D, Chen H, Zhang XL.

PLoS One. 2009 Dec 3;4(12):e8142. doi: 10.1371/journal.pone.0008142.

6.

Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach.

Fang X, Tan W.

Acc Chem Res. 2010 Jan 19;43(1):48-57. doi: 10.1021/ar900101s.

7.

Selection of DNA aptamers against glioblastoma cells with high affinity and specificity.

Kang D, Wang J, Zhang W, Song Y, Li X, Zou Y, Zhu M, Zhu Z, Chen F, Yang CJ.

PLoS One. 2012;7(10):e42731. doi: 10.1371/journal.pone.0042731.

8.

Screening and verification of ssDNA aptamers targeting human hepatocellular carcinoma.

Lu B, Wang J, Zhang J, Zhang X, Yang D, Wu L, Luo Z, Ma Y, Zhang Q, Ma Y, Pei X, Yu H, Liu J.

Acta Biochim Biophys Sin (Shanghai). 2014 Feb;46(2):128-35. doi: 10.1093/abbs/gmt130.

PMID:
24300391
9.

Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.

Rong Y, Chen H, Zhou XF, Yin CQ, Wang BC, Peng CW, Liu SP, Wang FB.

Oncotarget. 2016 Feb 16;7(7):8282-94. doi: 10.18632/oncotarget.6988.

10.

Comparison of whole-cell SELEX methods for the identification of Staphylococcus aureus-specific DNA aptamers.

Moon J, Kim G, Park SB, Lim J, Mo C.

Sensors (Basel). 2015 Apr 15;15(4):8884-97. doi: 10.3390/s150408884.

11.

Molecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated via Cell-SELEX.

Xu J, Teng IT, Zhang L, Delgado S, Champanhac C, Cansiz S, Wu C, Shan H, Tan W.

PLoS One. 2015 May 4;10(5):e0125863. doi: 10.1371/journal.pone.0125863.

12.

Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX.

Van Simaeys D, López-Colón D, Sefah K, Sutphen R, Jimenez E, Tan W.

PLoS One. 2010 Nov 1;5(11):e13770. doi: 10.1371/journal.pone.0013770.

13.

Cell-SELEX based selection and optimization of DNA aptamers for specific recognition of human cholangiocarcinoma QBC-939 cells.

Wan J, Ye L, Yang X, Guo Q, Wang K, Huang Z, Tan Y, Yuan B, Xie Q.

Analyst. 2015 Sep 7;140(17):5992-7. doi: 10.1039/c5an01055a.

PMID:
26181902
14.

Generating aptamers by cell-SELEX for applications in molecular medicine.

Ye M, Hu J, Peng M, Liu J, Liu J, Liu H, Zhao X, Tan W.

Int J Mol Sci. 2012;13(3):3341-53. doi: 10.3390/ijms13033341. Review.

15.

Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.

Li WM, Bing T, Wei JY, Chen ZZ, Shangguan DH, Fang J.

Biomaterials. 2014 Aug;35(25):6998-7007. doi: 10.1016/j.biomaterials.2014.04.112.

PMID:
24857291
16.

Using live cells to generate aptamers for cancer study.

Meng L, Sefah K, Colon DL, Chen H, O'Donoghue M, Xiong X, Tan W.

Methods Mol Biol. 2010;629:355-67. doi: 10.1007/978-1-60761-657-3_23.

PMID:
20387161
17.
18.

The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.

Hamula CL, Peng H, Wang Z, Newbigging AM, Tyrrell GJ, Li XF, Le XC.

J Mol Evol. 2015 Dec;81(5-6):194-209. doi: 10.1007/s00239-015-9711-y.

PMID:
26538121
19.

Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles.

Wang FB, Rong Y, Fang M, Yuan JP, Peng CW, Liu SP, Li Y.

Biomaterials. 2013 May;34(15):3816-27. doi: 10.1016/j.biomaterials.2013.02.018.

20.

Aptamers evolved from live cells as effective molecular probes for cancer study.

Shangguan D, Li Y, Tang Z, Cao ZC, Chen HW, Mallikaratchy P, Sefah K, Yang CJ, Tan W.

Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):11838-43.

Items per page

Supplemental Content

Support Center